Dr. Agarwal’s Strong Q3, Total Income Up 20.8% to ₹1,548 Crores
Dr. Agarwal’s Health Care Limited announced strong unaudited consolidated financial results. Total income for 9M’FY2026 soared by…
Kansai Nerolac Q3 FY26 Results Show Revenue Growth
Kansai Nerolac Paints Ltd (KNPL) announced its Q3 FY2026 results, reporting a net revenue of ₹1907.35 Crores, a 3.5% increase year-over-year.…
Dr. Agarwal’s Strong Q3 Performance with 21.9% YoY Income Growth
Dr. Agarwal’s Health Care Limited announced strong unaudited consolidated financial results. Total income for Q3 FY2026 reached INR 540…
Dr. Agarwal’s Health Care Revenue Surges 20.8% to ₹1,548 Crores in 9M’FY26
Dr. Agarwal’s Health Care Limited announced a significant 20.8% YoY increase in total income, reaching ₹1,548 Crores for the nine months…
SBI Life Q3 FY26 Earnings Conference Call Transcript
SBI Life reported a 19% growth in new business premium, reaching INR 313.3 billion. The company’s profit after tax increased by 4% to…
Aarti Drugs Declares Interim Dividend and Approves Key Personnel Changes
Aarti Drugs announced an interim dividend of ₹2 per equity share (20%) for the financial year 2025-26. The record date for the dividend is set…
Usha Martin Receives Cautionary Letter Regarding Shareholding Pattern
Usha Martin has received a cautionary letter from the exchange regarding its shareholding pattern for the quarter ended March 31, 2025. The…
Dishman Carbogen Amcis Q3 FY26 Results, Security Cover Report & Auditor Review
Dishman Carbogen Amcis Limited announced its Q3 FY26 financial results. Consolidated total income stood at ₹726.46 Crores. The company has…
Kansai Nerolac Q3 FY26 Results Show Revenue Growth, Impacted by New Labor Codes
Kansai Nerolac Paints Ltd (KNPL) announced its Q3 FY26 results, reporting a 3.5% increase in net revenue to ₹1907.35 Crores. EBITDA grew by…
Signature Global Reports Q3 & 9M FY2026 Financials, Pre-Sales Dip
Signature Global reported ₹2.8 billion revenue in Q3 FY26 and ₹14.9 billion for 9M FY26. Adjusted gross profit margin improved to 40% in Q3…